Concepedia

Author

Alex Chehrazi‐Raffle

City of HopeORCID

Also Known As

A. Chehrazi-Raffle, A. Chehrazi-raffle, Alex Chehrazi-Raffle, Alex Chehrazi‐Raffle, Alexander Chehrazi-Raffle, Alexander Chehrazi‐Raffle, Alexander M. Chehrazi-Raffle, Alexander Morteza Chehrazi-Raffle

187

Publications

2.4K

Citations

16

H-Index

29

Concepts

All Affiliations

City of HopeYale UniversityCity Of Hope National Medical CenterTranslational Genomics Research InstituteHuntsman Cancer Institute
AC

About

Alex Chehrazi‐Raffle is an author at City of Hope specializing in medicine, urology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

132

2

Immunology

4

4

107

3

Health Sciences

2

2

35

4

Microbiology

1

1

15

5

Pharmacology

1

1

20

Alex Chehrazi‐Raffle

×

14

Publications

767

Citations

12

H-Index

YearCitations

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot,

Nature Medicine

2022

427

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza,

Nature Medicine

2024

64

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy,

The Lancet

2024

54

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Alex Chehrazi‐Raffle, Luís Meza, Marice Alcantara,

Journal for ImmunoTherapy of Cancer

2021

37

Toxoplasma gondii Serology and Outcomes After Heart Transplantation: Contention in the Literature

Alex Chehrazi‐Raffle, Minh B. Luu, Zhenhua Yu,

Transplantation Proceedings

2015

25

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma

Zeynep Büşra Zengin, Caroline Weipert, Nicholas Salgia,

Clinical Cancer Research

2021

23

Barriers to Clinical Trial Implementation Among Community Care Centers

Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin,

JAMA Network Open

2024

23

Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma

Alex Chehrazi‐Raffle, Ramya Muddasani, Nazlı Dizman,

JCO Precision Oncology

2023

22

Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.

Hedyeh Ebrahimi, Luís Meza, Keehoon Lee,

Journal of Clinical Oncology

2023

20

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma

Nazlı Dizman, Ameish Govindarajan, Zeynep Büşra Zengin,

Clinical Genitourinary Cancer

2023

18

Page 1